News
After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy ...
said on Wednesday it has achieved a "final victory" in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity ...
The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines ... vaccine infringes multiple patents that cover its own Spikevax shot. Among the claims is that ...
After being hailed as a triumph of public-private drug development, Moderna's partnership with the US government on its COVID-19 vaccine ... Moderna's mRNA-1273 shot. The patent has been filed ...
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people from getting ...
Hosted on MSN29d
SK bioscience wins patent case against Moderna in Koreasaid Wednesday it had achieved a “final victory” in a patent invalidation case against Moderna, the global developer of the messenger RNA (mRNA) Covid-19 vaccine. SK bioscience filed a nullity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results